Affordable Access

Publisher Website

Pathological Consequence of Misguided Dendritic Cell Differentiation in Histiocytic Diseases-Chapter Five

Authors
Publisher
Elsevier Science & Technology
Identifiers
DOI: 10.1016/b978-0-12-417028-5.00005-3
Keywords
  • Dendritic Cell Lineage
  • Macrophages
  • Dc Differentiation
  • Histiocytic Disorders
  • Langerhans Cell Histiocytosis
  • Juvenile Xanthogranuloma
  • Erdheim–Chester Disease
  • Brafv600E
Disciplines
  • Biology
  • Medicine

Abstract

Abstract Histiocytic disorders represent a group of complex pathologies characterized by the accumulation of histiocytes, an old term for tissue-resident macrophages and dendritic cells. Langerhans cell histiocytosis is the most frequent of histiocytosis in humans and has been thought to arise from the abnormal accumulation of epidermal dendritic cells called Langerhans cells. In this chapter, we discuss the origin and differentiation of Langerhans cells and dendritic cells and present accumulated evidence that suggests that Langerhans cell histiocytosis does not result from abnormal Langerhans cell homeostasis but rather is a consequence of misguided differentiation programs of myeloid dendritic cell precursors. We propose reclassification of Langerhans cell histiocytosis, juvenile xanthogranuloma, and Erdheim–Chester disease as inflammatory myeloid neoplasias.

There are no comments yet on this publication. Be the first to share your thoughts.